Intracellular interferon triggers Jak/Stat signaling cascade and induces p53-dependent antiviral protection

Biochemical and Biophysical Research Communications

Volumn 329, Issue 3, 2005, Pages 1139-1146

  Shin Ya, Masaharu ^a   Hirai, Hideyo ^a   Satoh, Etsuko ^a   Kishida, Tsunao ^a,b   Asada, Hidetsugu ^a   Aoki, Fumiko ^a   Tsukamoto, Masako ^a   Imanishi, Jiro ^a   Mazda, Osam ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Louis Pasteur Center for Medical Research   (Japan)

Author keywords

Autocrine; Interferon; p53; RNA interference; STAT1

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; CYTOKINE; JANUS KINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN P53; RNA; SERINE; STAT1 PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYO; GENE CONSTRUCT; GENE DELETION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MOLECULE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 14844327753     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.02.088     Document Type: Article

References (31)

1. J. Sanceau, P. Sondermeyer, F. Beranger, R. Falcoff, and C. Vaquero Intracellular human gamma-interferon triggers an antiviral state in transformed murine L cells Proc. Natl. Acad. Sci. USA 84 1987 2906 2910
2. A. Will, U. Hemmann, F. Horn, M. Rollinghoff, and A. Gessner Intracellular murine IFN-gamma mediates virus resistance, expression of oligoadenylate synthetase, and activation of STAT transcription factors J. Immunol. 157 1996 4576 4583
3. C.M. Ahmed, M.A. Burkhart, M.G. Mujtaba, P.S. Subramaniam, and H.M. Johnson The role of IFNgamma nuclear localization sequence in intracellular function J. Cell Sci. 116 2003 3089 3098
4. B.E. Bejcek, D.Y. Li, and T.F. Deuel Transformation by v-sis occurs by an internal autoactivation mechanism Science 245 1989 1496 1499
5. C.E. Dunbar, T.M. Browder, J.S. Abrams, and A.W. Nienhuis COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth Science 245 1989 1493 1496
6. C.M. Ahmed, K.N. Wills, B.J. Sugarman, D.E. Johnson, M. Ramachandra, T.L. Nagabhushan, and J.A. Howe Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice J. Interferon Cytokine Res. 21 2001 399 408
7. M.N. Rutherford, A. Kumar, B. Coulombe, D. Skup, D.H. Carver, and B.R. Williams Expression of intracellular interferon constitutively activates ISGF3 and confers resistance to EMC viral infection J. Interferon Cytokine Res. 16 1996 507 510
8. M. Roth, M. Nauck, M. Tamm, A.P. Perruchoud, R. Ziesche, and L.H. Block Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells Proc. Natl. Acad. Sci. USA 92 1995 1312 1316
9. G.R. Stark, I.M. Kerr, B.R. Williams, R.H. Silverman, and R.D. Schreiber How cells respond to interferons Annu. Rev. Biochem. 67 1998 227 264
10. T. Kishida, H. Asada, E. Satoh, S. Tanaka, M. Shinya, H. Hirai, M. Iwai, H. Tahara, J. Imanishi, and O. Mazda In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice Gene Ther. 8 2001 1234 1240
11. M. Shin-Ya, O. Mazda, C. Tsuchihara, H. Hirai, J. Imanishi, and M. Takeuchi Interleukin-2 abolishes myeloid cell accumulation induced by Lewis lung carcinoma J. Interferon Cytokine Res. 23 2003 631 638
12. H. Maruyama-Tabata, Y. Harada, T. Matsumura, E. Satoh, F. Cui, M. Iwai, M. Kita, S. Hibi, J. Imanishi, T. Sawada, and O. Mazda Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer Gene Ther. 7 2000 53 60
13. J. Imanishi, S. Hoshino, A. Hoshino, T. Oku, M. Kita, and T. Kishida New simple dye-uptake assay for interferon Biken J. 24 1981 103 108
14. G. Kaerber Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche Arch. Exp. Pathol. Pharmak. 162 1931 480 483
15. Y. Li, K.K. Srivastava, and L.C. Platanias Mechanisms of type I interferon signaling in normal and malignant cells Arch. Immunol. Ther. Exp. (Warsz) 52 2004 156 163
16. A. Takaoka, S. Hayakawa, H. Yanai, D. Stoiber, H. Negishi, H. Kikuchi, S. Sasaki, K. Imai, T. Shibue, K. Honda, and T. Taniguchi Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence Nature 424 2003 516 523
17. S.Y. Shieh, M. Ikeda, Y. Taya, and C. Prives DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 Cell 91 1997 325 334
18. P.A. Sandstrom, D. Pardi, C.S. Goldsmith, D. Chengying, A.M. Diamond, and T.M. Folks bc1-2 expression facilitates human immunodeficiency virus type-1 mediated cytopathic effects during acute spreading infections J. Virol. 70 1996 4617 4622
19. N. Stahl, T.G. Boulton, T. Farruggella, N.Y. Ip, S. Davis, B.A. Witthuhn, F.W. Quelle, O. Silvennoinen, G. Barbieri, and S. Pellegrini Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components Science 263 1994 92 95
20. D.S. Finbloom, and K.D. Winestock IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes J. Immunol. 155 1995 1079 1090
21. J.G. Drachman, K.M. Millett, and K. Kaushansky Thrombopoietin signal transduction requires functional JAK2, not TYK2 J. Biol. Chem. 274 1999 13480 13484
22. K. Shimoda, K. Kato, K. Aoki, T. Matsuda, A. Miyamoto, M. Shibamori, M. Yamashita, A. Numata, K. Takase, S. Kobayashi, S. Shibata, Y. Asano, H. Gondo, K. Sekiguchi, K. Nakayama, T. Nakayama, T. Okamura, S. Okamura, Y. Niho, and K. Nakayama Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function Immunity 13 2000 561 571
23. J.S. Bonifacino, and B.S. Glick The mechanisms of vesicle budding and fusion Cell 116 2004 153 166
24. S. Rodig, M. Meraz, J. White, P. Lampe, J. Riley, C. Arthur, K. King, K. Sheehan, L. Yin, D. Pennica, E.J. Johnson, and R. Schreiber Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses Cell 93 1998 373 383
25. M. Meraz, J. White, K. Sheehan, E. Bach, S. Rodig, A. Dighe, D. Kaplan, J. Riley, A. Greenlund, D. Campbell, K. Carver-Moore, R. DuBois, R. Clark, M. Aguet, and R. Schreiber Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway Cell 84 1996 431 442
26. J. Durbin, R. Hackenmiller, M. Simon, and D. Levy Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway Cell 84 1996 443 450
27. U. Muller, U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet Functional role of type I and type II interferons in antiviral defense Science 264 1994 1918 1921
28. J. Ragimbeau, E. Dondi, A. Alcover, P. Eid, G. Uze, and S. Pellegrini The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression EMBO J. 22 2003 537 547
29. J.E. Darnell Jr. STATs and gene regulation Science 277 1997 1630 1635
30. P.A. Townsend, T.M. Scarabelli, S.M. Davidson, R.A. Knight, D.S. Latchman, and A. Stephanou STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis J. Biol. Chem. 279 2004 5811 5820
31. F. Baran-Marszak, J. Feuillard, I. Najjar, C. Le Clorennec, J.M. Bechet, I. Dusanter-Fourt, G.W. Bornkamm, M. Raphael, and R. Fagard Differential roles of STAT1{alpha} and STAT1{beta} in Fludarabine-induced cell cycle arrest and apoptosis in human B-cells Blood 2004